Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Knee Osteoarthritis
NCT03913442Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- May 2019
- Primary completion
- Jan 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Colchicine with Placebo (2 arms). Primary endpoint: Visual Analog Scale Pain Score at 3 months. Started May 2019; status: completed.
02
Drugs
colchicine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03913442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03913442.